The new draft recommendations from the US Preventive Services Task Force make a significant change to the previous colorectal cancer screening recommendations. This month, Dr. Campos-Outcalt describes that change and provides a look at the financial implications (as stipulated by the Affordable Care Act) of the screening method chosen.
